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To the Editor: 30 
Exercise training represents a cornerstone of contemporary cardiac rehabilitation. Recently, high-31 
intensity interval training (HIT) has been popularized for heart failure (HF) patients (1) and may serve 32 
as a superior mode of exercise compared to traditional endurance exercise training. However, there is 33 
controversy regarding the safety (2) and the direct effects of HIT on the heart. Previous studies have 34 
demonstrated that an acute bout of exercise leads to an increase in cardiac troponin (cTn), a biomarker 35 
for cardiac injury, and B-type natriuretic peptide (BNP), a marker for cardiomyocyte stress (3,4). 36 
Exercise-induced elevation in these biomarkers is related to exercise intensity and duration (4,5), and 37 
may occur to a larger extend in patients with cardiovascular risk factors (6). To date, no previous 38 
study: 1. compared changes in cTn and BNP between endurance exercise and HIT, and 2. explored 39 
differences in exercise-induced changes in cTn and BNP between HF patients and controls.  40 
 41 
We included 13 pharmacologically and clinically stable HF patients NYHA-class I-III (67±7 yrs; 42 
male:female 12:1) with impaired left ventricular ejection fraction (35±8%) and 14 healthy controls 43 
(60±6 yrs; male:female 11:3, Table 1). The study procedures conformed to the Declaration of Helsinki 44 
and were approved by the local ethics committee. All subjects provided written informed consent. A 45 
maximal incremental cycling test was performed on a cycle ergometer (Lode Excalibur 46 
v1.52/Ergoline, Ergoselect 200k) to determine peak oxygen uptake (VO2peak). As expected, we found 47 
that VO2peak was markedly lower in HF patients than in healthy controls (18.7±4.3 versus 37.2±10.8 48 
mLO2/kg/min, P<0.001). On visit 2 and 3, subjects performed an isocaloric endurance exercise bout 49 
(30-minutes at 65%VO2peak) and HIT (10*1-minute at 90%VO2peak, alternated by 2.5-minutes at 50 
40%VO2peak) in randomized order. Both exercise bouts included comparable warm-up (10-minutes at 51 
40%VO2peak) and cool-down (5-minutes at 30%VO2peak). Exercise intensity was verified using a heart 52 
rate monitor (Polar Electro Oy, RS800, Kempele, Finland). To assess cTnI- and BNP-levels, venous 53 
blood samples were obtained at baseline (BASE), post-exercise (POST) and 2-hours post-exercise 54 
(2H-POST), and analyzed using high-sensitive cTnI-assays (ADVIA Centaur, Siemens, detection 55 
limit: 6 ng/L, upper reference limit: 40 ng/L) and BNP-assays (ADVIA Centaur, Siemens, detection 56 
limit: 2 pg/mL, upper reference limit: 100 pg/mL). Changes in cTnI- and BNP-levels after exercise 57 




(ΔcTnI, ΔBNP) were analyzed using 3-way Linear Mixed Model analysis, including ‘time’ (ΔBASE-58 
POST, ΔBASE-2H-POST), ‘group’ (HF, controls), and ‘exercise-mode’ (HIT, endurance). cTnI data 59 
of the HIT session of one HF patient were classified as statistical outliers (value>2*SD) and hence 60 
excluded from analysis.  61 
 62 
We found that baseline cTnI- and BNP-levels were higher in HF patients compared to controls (cTnI: 63 
39±133 versus 4±10 ng/L, BNP: 80±86 versus 8±7 pg/mL, both P<0.001), a characteristic observation 64 
when examining HF patients and their healthy peers. Interestingly, exercise-induced ΔcTnI was 65 
comparable between both exercise bouts, but also did not differ between groups (Figure 1A). Exercise-66 
induced ΔBNP was significantly larger in HF patients compared to controls. Nonetheless, we found no 67 
differences in ΔBNP-levels between both exercise-modes (Figure 1B).  68 
 69 
This pilot work indicates that exercise-induced changes in cTnI and BNP were similar between 70 
endurance exercise (performed according to current cardiac rehabilitation guidelines (7)) and a single 71 
bout of HIT. Although a higher exercise-intensity is associated with a larger cTn-release (4,5), HIT did 72 
not induce a larger release in cTnI compared to endurance exercise. We speculate that, despite being 73 
performed at high-intensity, the short duration of high-intensity bouts prevents excessive cardiac load 74 
(8) and, therefore, does not induce significant biomarker release. Although our observations do not 75 
provide information on safety, our data demonstrates that HIT does not cause larger release of 76 
biomarkers related to cardiac injury compared to endurance exercise. 77 
 78 
Previous work suggested that cardiovascular risk and/or disease is associated with a larger cTnI-79 
release after exercise (6). In contrast, we found similar changes in cTnI in both groups, whilst HF 80 
patients show larger BNP increases than controls. Since BNP is related to cardiomyocyte stress, this 81 
finding suggests a higher cardiac load during exercise in HF patients compared to controls. Future 82 
studies with hemodynamic monitoring are recommended to confirm these observations. Combined, 83 
these data suggest that, despite larger myocardial stress in HF patients, endurance exercise nor HIT 84 
lead to excessive release of cardiac biomarkers indicative of acute cardiac damage.  85 
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Table 1. Baseline characteristics of HF patients and healthy controls.  123 
Parameter Heart failure  Controls  P-value 
Age (yrs) 67±7 60±6 0.014 
Sex (male:female) 12:1 11:3 0.315 
BMI (kg/m2) 28.5±6.5 24.7±4.6 0.088 
LVEF 35±8 N.A. N.A. 
Etiology (ischemic:non-ischemic) 7:6 N.A. N.A. 
NYHA class (I:II:III) 1:10:2 N.A. N.A. 
Systolic blood pressure (mmHg) 130±17 130±14 0.988 
Diastolic blood pressure (mmHg) 79±9 85±10 0.168 
Resting heart rate (/min) 59±8 60±10 0.792 
Peak heart rate (/min) 129±16 165±17 <0.001 
Peak oxygen uptake (mlO2/kg/min) 18.7±4.3 37.2±10.8 <0.001 
cTnI level (ng/L) 1 39±133 4±10 <0.001 
BNP level (pg/mL)1 80±86 8±7 <0.001 
Data is presented as mean ± SD. P-value refers to an unpaired Student’s t-test for continuous 124 
variables and the Chi-Square test for sex. 1P-value refers to a Mann-Whitney U test. BMI; 125 
body mass index. LVEF; left ventricular ejection fraction. N.A.; not available. cTnI; cardiac 126 
troponin I. BNP; brain natriuretic peptide.  127 
  128 




Figure 1  129 
Changes in cTnI (A) and BNP levels (B) immediately after (POST) and two hours after (2H-POST) 130 
exercise compared to baseline. HIT; high-intensity interval training. Error bars represent SE. *group-131 
effect P<0.05. 132 
 133 
134 




Figure 1 135 
 136 
